Skip to content
★ Sign in to follow
Total declarations
3
Company
1
▲ Purchases (1 ops.)
€1.8M
▼ Sales (0 ops.)
—

Latest filing published 13 Nov 2019 for TELA Bio, Inc..

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Adele C. Oliva: trading record in brief

This profile gathers the share dealings of Adele C. Oliva in TELA Bio, Inc. We count 3 filings; the first trade dates from 8 November 2019 and the latest from 13 November 2019.

The open-market record is one-sided, with 1 purchase worth €1.8M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The newest entry dates from 13 November 2019: a transaction, in TELA Bio, Inc. The last purchase on record was published on 13 November 2019, which is 2,553 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Adele C. Oliva

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    DirectorExecutivesTELA Bio, Inc.
    0SEC
    345,489 sharesCommon StockSEC:0001192482-19-000420:1
  • ●
    DirectorExecutivesTELA Bio, Inc.
    0SEC
    516,947 sharesCommon StockSEC:0001192482-19-000420:2
  • ▲
    DirectorExecutivesTELA Bio, Inc.

    Same trade as the filing by Quaker BioVentures II LP, counted once

    2M USD37SEC
    153,846 shares@ US$13.00100.0% of flowCommon StockSEC:0001192482-19-000420:0
    Canonical exit: 6 Feb 2020 (T+90)

3 of 2 declarations